PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.570
-0.010 (-0.28%)
At close: Jun 27, 2025, 4:00 PM
3.600
+0.030 (0.84%)
After-hours: Jun 27, 2025, 7:44 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $36.38 million as of June 27, 2025. Its market cap has increased by 68.90% in one year.
Market Cap
36.38M
Enterprise Value
37.17M
1-Year Change
68.90%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $36.38M, a decrease of -55.87%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 36.38M | 75.90% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |